Rigel Pharmaceuticals Inc (RIGL)
Short-Term Debt
$39.89M
Quarterly · Period ending: · USD
RIGL Short-Term Debt
Latest reported$39.89Mperiod ending
Latest reported$39.89Mperiod ending
RIGL Quarterly Short-Term Debt ($2.95M → $39.89M)
Quarterly short-term debt
High-resolution chart · PNG
RIGL short-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Short-Term Debt (USD) |
|---|---|
| 39,892,000 | |
| 30,501,000 | |
| 30,426,000 | |
| 30,355,000 | |
| 22,878,000 | |
| 15,271,000 | |
| 7,557,000 | |
| 466,000 | |
| 639,000 | |
| 15,489,000 | |
| 7,921,000 | |
| 673,000 | |
| 466,000 | |
| 449,000 | |
| 1,133,000 | |
| 3,314,000 | |
| 5,811,000 | |
| 8,296,000 | |
| 9,892,000 | |
| 9,574,000 | |
| 9,221,000 | |
| 8,917,000 | |
| 8,621,000 | |
| 8,334,000 | |
| 8,054,000 | |
| 7,780,000 | |
| 7,272,000 | |
| 7,255,000 | |
| 7,002,000 | |
| 6,755,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 3,112,000 | |
| 3,058,000 | |
| 0 | |
| 2,953,000 | |
| 2,902,000 | |
| 2,852,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 134,000 | |
| 315,000 | |
| 549,000 | |
| 755,000 | |
| 0 | |
| 941,000 | |
| 990,000 | |
| 1,061,000 | |
| 1,114,000 | |
| 1,167,000 | |
| 1,226,000 | |
| 1,339,000 | |
| 1,040,000 | |
| 1,020,000 | |
| 954,000 | |
| 990,000 | |
| 1,019,000 | |
| 1,151,000 | |
| 1,208,000 | |
| 1,269,000 | |
| 1,278,000 | |
| 1,257,000 | |
| 1,218,000 | |
| 1,070,000 | |
| 1,022,000 | |
| 1,165,000 | |
| 1,361,000 | |
| 1,321,000 | |
| 1,541,000 | |
| 1,780,000 | |
| 2,024,000 | |
| 2,259,000 | |
| 2,464,000 | |
| 2,760,000 | |
| 3,083,000 | |
| 3,388,000 | |
| 3,706,000 | |
| 3,704,000 | |
| 3,292,000 | |
| 3,171,000 | |
| 3,162,000 |